View Older Stories View More Recent Stories
-
Nuo Therapeutics Announces Execution of Limited Consent With Deerfield Management Through December 4, 2015
-
Nuo Therapeutics Announces 3rd Quarter 2015 Financial Results
-
Discovery Labs Provides Business Update and Reports Third Quarter 2015 Financial Results
-
Nuo Therapeutics to Hold Third Quarter 2015 Conference Call on Friday, November 13 at 8:00 a.m. Eastern Time
-
Conventus Orthopaedics Raises $23.5 Million to Fuel Conventus Cage Commercialization and Technology Development
-
Nuo Therapeutics Responds to Favorable CMS Hospital Outpatient Payment Final Ruling for Aurix System
-
Nuo Therapeutics Responds to Favorable CMS Hospital Outpatient Payment Final Ruling for Aurix System
-
Deerfield Management Announces Partnership with Gregory Sorensen and Deerfield Imaging
-
AAC Holdings, Inc. Reports Third Quarter 2015 Results
-
Nuo Therapeutics Executes Amended Licensing Agreement With Arthrex
-
Audentes Therapeutics Raises $65 Million in Series C Financing
-
Unusual 11 Mid-Day Movers 10/12: (MBLX) (ALIM) (NVCR) Higher; (MHR) (SXC) (BCEI) Lower
-
Janet S. Vergis Appointed to Impax Laboratories Board of Directors
-
PlacementTracker Publishes Third Quarter 2015 PIPE Market League Tables
-
Breathe Technologies, Inc. Will Present And Exhibit At Upcoming Medical Technology Conferences
-
Deerfield Makes $50 Million Commitment to AAC Holdings to Expand Clinical Care and Treatment with Additional $50 Million Incremental Facility
-
AAC Holdings Enters into $50 Million Capital Commitment with Deerfield Management and an Additional $50 Million Incremental Facility
-
U.S. biotech bloodbath hits hedge funds but some bargains emerge
-
Form 4 REGENXBIO Inc. For: Sep 22 Filed by: DEERFIELD MANAGEMENT CO
-
Deerfield Leads Funding in Creation of Akari Therapeutics
-
Breathe Technologies, Inc. Announces HCPCS Reimbursement Codes For Life2000 Ventilation System
-
Nuo Therapeutics Launches Educational Program to Support Wound Care Centers in Transition to ICD-10
-
Nuo Therapeutics Launches Educational Program to Support Wound Care Centers in Transition to ICD-10
-
New York Digital Health Accelerator Announces Selected Companies for 2015 Program
-
AveXis Secures $65 Million in Financing
-
Nuo Therapeutics Provides Updates on VA Commercialization Efforts
-
Nuo Therapeutics Provides Updates on VA Commercialization Efforts
-
Horizon Pharma (HZNP) Amends Prelim. Solicitation in Depomed (DEPO) to Nominate New Board Members
-
Horizon Pharma plc to Amend Preliminary Solicitation Statement to Include Proposed Nominees for Depomed's Board
-
Tribute Pharmaceuticals Announces Second Quarter 2015 Results
-
Form 13F-HR DEERFIELD MANAGEMENT CO For: Jun 30
-
Nuo Therapeutics Reports Second Quarter 2015 Results and Operational Update
-
Nuo Therapeutics Reports Second Quarter 2015 Results and Operational Update
-
Rhythm Subsidiary Raises $40 Million in Oversubscribed Financing
-
Discovery Labs Provides Business Update and Reports Second Quarter 2015 Financial Results
-
Deerfield Invests $20 million in Editas Medicine
-
Editas Medicine Raises $120 Million to Advance Genome Editing
-
Nuo Therapeutics' Au Study Goes Digital
-
Deerfield Launches $550 Million Healthcare Venture-Capital Fund
-
Nuo Therapeutics and American Academy of Professional Coders Partner to Create First-Ever Wound Care Education Series
-
Nuo Therapeutics and American Academy of Professional Coders Partner to Create First-Ever Wound Care Education Series
-
Discovery Labs Announces Completion of $40.25 Million Public Offering
-
PlacementTracker Publishes First Half 2015 PIPE Market League Tables
-
SecurityScorecard Releases Security Benchmark Report, Finds Banking Malware Targets Employees, And Partner Company Employees, Across All Industries
-
Nuo Therapeutics to Support 35th Annual National Veterans Wheelchair Games
-
Nuo Therapeutics to Support 35th Annual National Veterans Wheelchair Games
-
CytomX Raises $70 Million in Series D Financing
-
Breathe Technologies, Inc. Announces FDA Clearance for Life2000 Ventilation System
-
Breathe Technologies Named Winner of the 2015 Red Herring Top 100 North America Award
-
Deerfield Announces a $300 Million Commitment to Create and Build Aralez Pharmaceuticals Ltd.

